In March 2011, a Canadian backhoe operator unearthed what paleontologists now call one of the most extraordinary fossil finds ...

AstraZeneca’s Alexion division has received FDA approval for Koselugo (selumetinib) to treat adults with NF1 who have symptomatic, inoperable plexiform neurofibromas. The decision is based on strong ...